receptor 8 were appended to the 5 and 15 porphyrin
substitution positions with the goal of allowing the simul-
taneous binding of the saccharide substituents on both sides
of the ginsenoside analyte (i.e., Figure 2).
The first step in the synthesis of receptor 8 involved the
formation of zinc(II) porphyrin 3. This was accomplished
using the traditional Lindsey procedure10 in three steps with
an overall 19% yield (Scheme 1). Porphyrin 3 contains cyano
groups as the latent amine functionalities. It also contains
phenolic units, which were designed to serve as attachment
sites for solubilizing groups. Substitution of the phenolic units
of 3 with triethyleneglycol chains11 to give 4, followed by
protection with tetrahydropyran, yielded intermediate 5 in
32% yield for two steps.12 Reduction of the cyano units was
accomplished with the use of LAH.13 Subsequent heating
in aqueous HCl served to oxidize any reduced macrocycle
and cleave the protecting groups. This step also removed
the zinc(II) ion from the porphyrin core. Recovered porphyrin
6, obtained in 62% yield, was then used in the reductive
amination of 2-formylphenylboronic acid (7).14 The final
product (8) was purified through reverse-phase chromatog-
raphy and isolated in quantities of ca. 20 mg (44% yield for
two steps).
The absorbance and fluorescence properties of 8 were
found to be consistent with those previously reported for free
base tetraphenylporphyrin macrocycles.10 The absorbance
intensity at the Soret band (λmax ) 420 nm) was found to be
linear with the concentration up to 3.5 µM in a 9:1 DMSO:
water solution buffered to pH 7.4. Efforts to study higher
concentrations were precluded due to the high absorptivity
of the receptor. The observed linearity was taken as evidence
of minimal aggregation at concentrations e3.5 µM in this
solvent mixture.
The effects of ginsenosides on the optical properties of 8
were then explored using a receptor concentration of 3 µM.
While little change was observed in the absorption spectrum,
the addition of ginsenosides led to significant quenching of
the emission of receptor 8. Fluorescence titration experiments
revealed that the degree of quenching varied as a function
of the ginsenoside structure (Figure 3).
The quenching curves were then fit to a 1:1 binding
equation to estimate the association constant of the underly-
ing interactions.15 The method used was based on a previous
report that allowed for the calculation of binding constants
using the change in absorbance relative to concentration of
Figure 1. Examples of ginsenoside structures. Glc ) ꢀ-D-glucose;
Xyl ) ꢀ-D-xylose; Rha ) R-L-rhamnose.
in terms of quality control.5 Normally, ginseng products are
analyzed through a time-consuming HPLC process.6 The
resulting inefficiency is providing a motivation to develop
improved methods for the analysis of ginsenoside compo-
nents. Despite recent efforts in this area,7 a simple optical
assay for ginsenosides has not been reported.
To address the need for improved ginsenoside sensing,
we designed and synthesized the boronic acid appended
porphyrin 8 (Scheme 1).8 This hybrid system was expected
to serve as a supramolecular receptor for ginsenosides.
Specifically, it was expected that the hydrophobic porphyrin
ring would interact with the steroid core of the ginsenosides
while also providing a large scaffold for the appendage of
sugar binding units. Boronic acids were chosen to serve this
latter purpose. These groups have been used in some of the
most successful synthetic saccharide receptors reported to
date and are known to form reversible covalent bonds with
1,2- and 1,3-cis-diols.9 The two boronic acid groups in
(5) Wills, R. B. H.; Stuart, D. L. Production of high quality Australian
ginseng: a report for the Rural Industries Research and DeVelopment
Corporation; RIRDC: Barton, A.C.T., 2001.
(10) Lindsey, J. S. Porphyrin Handb. 2000, 1, 45.
(11) (a) van Ameijde, J.; Liskamp, R. M. J. Org. Biomol. Chem. 2003,
1, 2661. (b) Wei, W. H.; Wang, Z.; Mizuno, T.; Cortez, C.; Fu, L.;
Sirisawad, M.; Naumovski, L.; Magda, D.; Sessler, J. L. Dalton Trans. 2006,
1934.
(6) Fuzzati, N. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2004,
812, 119.
(7) For recent reviews, see: (a) Jiang, Y.; David, B.; Tu, P.; Barbin, Y.
Anal. Chim. Acta 2010, 657, 9. (b) Yap, K. Y.; Chan, S. Y.; Weng Chan,
Y.; Sing Lim, C. Assay Drug DeV. Technol. 2005, 3, 683.
(8) For examples of other boronic acid-appended porphyrin receptors,
please see: (a) Imada, T.; Kijima, H.; Takeuchi, M.; Shinkai, S. Tetrahedron
1996, 52, 2817. (b) Sugasaki, A.; Ikeda, M.; Takeuchi, M.; Shinkai, S.
Angew. Chem., Int. Ed. 2000, 39, 3839. (c) Sugasaki, A.; Sugiyasu, K.;
Ikeda, M.; Takeuchi, M.; Shinkai, S. J. Am. Chem. Soc. 2001, 123, 10239.
(d) Hirata, O.; Kubo, Y.; Takeuchi, M.; Shinkai, S. Tetrahedron 2004, 60,
11211. (e) Zhang, C.; Suslick, K. S. J. Porphyrins Phthalocyanines 2005,
9, 659.
(12) Wuts, P. G. M.; Greene, T. W. Greene’s ProtectiVe Groups in
Organic Synthesis, 4th ed.; John Wiley & Sons, Inc.: Hoboken, 2007.
(13) Carcel, C. M.; Laha, J. K.; Loewe, R. S.; Thamyongkit, P.;
Schweikart, K. H.; Misra, V.; Bocian, D. F.; Lindsey, J. S. J. Org. Chem.
2004, 69, 6739.
(14) (a) Cabell, L. A.; Monahan, M.-K.; Anslyn, E. V. Tetrahedron Lett.
1999, 40, 7753. (b) Wiskur, S. L.; Lavigne, J. J.; Ait-Haddou, H.; Lynch,
V.; Chiu, Y. H.; Canary, J. W.; Anslyn, E. V. Org. Lett. 2001, 3, 1311.
(15) We presumed a 1:1 binding stoichiometry for the purpose of
estimating the overall strength of binding interactions. The low concentration
of receptor 8 required to prevent aggregation, particularly as compared to
the concentration of the ginsenoside guests, precluded efforts to carry out
continuous variation (Job plot) experiments.
(9) For recent reviews, see: (a) Mader, H. S.; Wolfbeis, O. S. Microchim.
Acta 2008, 162, 1. (b) Jin, S.; Cheng, Y.; Reid, S.; Li, M.; Wang, B. Med.
Res. ReV. 2010, 30, 171.
Org. Lett., Vol. 12, No. 21, 2010
4805